NOVELLI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 4.552
Totale 4.552
Nazione #
IT - Italia 4.552
Totale 4.552
Città #
Genova 3.704
Rapallo 541
Genoa 280
Vado Ligure 19
Bordighera 8
Totale 4.552
Nome #
null 200
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 185
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 157
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 134
Gold(I) complexes as antimicrobial agents 132
Acridine derivatives as anti-BVDV agents 131
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 130
Formation of basic compounds during the indole cyclization of ketone phenylhydrazones 128
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 127
1-(Arylalkyl)quinolizidine derivatives and thio-isosteric analogues as ligands for sigma receptors 121
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 118
Spiro[1,2,4-benzotriazine-3(4H),4’-(1’-substituted)-piperidines] and related compounds as ligands for sigma receptors 117
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 116
Synthesis and pharmacological evaluation of some thiolupinine derivatives 115
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 110
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 110
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 109
Quinolizidine derivatives with antitubercular activity 109
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 106
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 106
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells 103
Triorganotin compounds as antimicrobial agents 102
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 102
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 101
Novel Sigma Binding Site Ligands as Inhibitors of Cell Proliferation in Breast Cancer 99
New arylsparteine derivatives as positive inotropic drugs 99
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 95
null 94
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 94
Preparation and pharmacological activities of spiro[3,4-dihydro-6/7-R-1,2,4-benzotriazine-3,4'-(1'-substituted)piperidines] 92
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 92
Synthesis and biological investigations of 1-(tetrahydropyran-2'-yl)- and 1-(tetrahydrofuran-2'-yl)-benzimidazoles and 1/2-(tetrahydropyran-2'-yl)- and 1/2-(tetrahydro-furan-2'-yl)benzotriazoles 89
Quinolizidine derivatives as ligands for sigma receptors 86
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 84
Synthesis and preliminary pharmacological evaluation of 3-[2-(1-aryl-piperazin-4-yl)ethyl]-3,4-dihydro-3-methyl-6-R-1,2,4-benzotriazines 81
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 76
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 75
Inhibitory properties of triethylphenosphine goldlupinylsulfide in adjuvant-induced arthritis in rats 74
Antitumor activity of a new o rally active organotin compound: a preliminare study in murine tumor models 71
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound 67
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 66
Novel organotins as antitumor agents 64
Thiolupinine and some derivatives of pharmacological interest 59
Preparazione e attività farmacologica di ammido-derivati 3-metil-3,4-diidro benzo e pirido-1,2,4-triazin-3-acetici 38
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS 30
Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride 29
Totale 4.623
Categoria #
all - tutte 12.946
article - articoli 12.562
book - libri 0
conference - conferenze 384
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.318 0 31 73 87 122 136 200 80 185 208 144 52
2020/2021322 24 22 68 16 11 31 15 21 31 33 24 26
2021/2022607 19 37 42 87 13 37 31 148 13 54 28 98
2022/2023614 47 20 12 56 114 119 2 53 91 1 93 6
2023/2024209 11 40 3 33 11 48 5 11 5 6 15 21
2024/202525 13 12 0 0 0 0 0 0 0 0 0 0
Totale 4.623